More recently Conway et al. (analysis of 935 CpG sites in 517 breast tumours from the Carolina Breast Cancer Study) identified breast cancer DNA methylation to be associated with hormone receptor status, subtype and TP53 mutation status [237]. The gene discussed is TP53; the disease is breast carcinoma.